Compare USD.AI (CHIP) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
USD.AI vs Enzyme — how do they compare? USD.AI trades at Rp406.64 (market cap Rp812,85M, Rp150,29M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: USD.AI is far larger — about 6.1× Enzyme's market cap, and USD.AI's supply is capped (2B / 10B CHIP (20%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold USD.AI for 4 Days and Enzyme for 29 Days on average.
| CHIP | MLN | |
|---|---|---|
Market Cap | Rp812,85M | Rp134,13M |
Volume (24h) | Rp150,29M | Rp104,56M |
Circulating Supply | 2B / 10B CHIP (20%) | 3,3M MLN |
Typical Hold Time | 4 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
USD.AI is currently trading at Rp414 with a bearish technical outlook, showing oversold conditions on short-term RSI but strong selling pressure from moving averages. The token trades near its R1 resistance at Rp412 with support at Rp387. With only 20% of the 10M max supply in circulation and low 4-day average hold time, the project shows early-stage tokenomics with limited network adoption metrics available.
Overall outlook remains cautious due to bearish technical signals and limited fundamental developments. Key opportunities include potential oversold bounce from RSI levels, while major risks involve low liquidity (Rp831M market cap), high volatility, and lack of recent ecosystem updates that could impact token utility and adoption trajectory.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About USD.AI
CHIP is the native asset of USD.AI, a protocol that connects blockchain-based finance with AI computing infrastructure. The ecosystem facilitates funding for GPU resources used in AI workloads and links digital assets with real-world compute operations through tokenized infrastructure and on-chain financial mechanisms.
Read more on CHIP →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
